Stent, method for processing stent, and method of stenting a patient
OwnerWolfgang Daum, Axel Winkelinventors
Life of this patent
Estimating the term…
Abstract
The subject invention pertains instruments for use in nuclear spin tomography comprising a metal alloy comprising aluminum, vanadium, and titanium. In a specific embodiment, the subject invention relates to cardiovascular stents which can exhibit a low incidence of artifacts and are viewable in a nuclear spin tomography unit. The subject invention also pertains to a method for processing instruments for use in nuclear spin tomography. Spin processing can comprise application of a wet chemical etching solution. In a specific embodiment, the wet chemical etching solution can comprise three parts hydrochloric acid and two parts saltpeter acid.
Claims23
1-5. (canceled)
A method for control of in-stent-restenosis, comprising:
- positioning a stent in a vessel, wherein the stent comprises TIA13V2.5;
- and
- viewing in-stent-restenosis within an inner lumen of the stent with nuclear spin tomography, wherein the TIA13V2.5 exhibits a low incidence of artifacts in nuclear spin tomography, wherein viewing in-stent-restenosis within the inner lumen of the stent with nuclear spin tomography is useful for control of in-stent-restenosis.
A method for control of in-stent-restenosis, comprising:
- positioning a stent in a vessel, wherein the stent comprises TIA16V4;
- and
- viewing in-stent-restenosis within an inner lumen of the stent with nuclear spin tomography, wherein the TIA16V4 exhibits a low incidence of artifacts in nuclear spin tomography, wherein viewing in-stent-restenosis within the inner lumen of the stent with nuclear spin tomography is useful for control of in-stent-restenosis.
A method of stenting a patient, comprising:
- stenting a patient with a stent, wherein the stent comprises:
- TIA13V2.5, wherein the TIA13V2.5 exhibits a low incidence of artifacts in nuclear spin tomography.
A method of stenting a patient, comprising:
- stenting a patient with a stent, wherein the stent comprises TIA16V4, wherein the TIA16V4 exhibits a low incidence of artifacts in nuclear spin tomography.
A method of stenting a patient, comprising:
- stenting a patient with a stent processed with tools containing magnetizing components, wherein prior to stenting the patient exposing the surface of the stent processed with tools containing magnetizing components to an etching solution that etches the magnetizing components, wherein exposing the surface of the stent processed with tools containing magnetizing components reduces surface magnetism of the stent, wherein reducing surface magnetism of the stent reduces the occurrence of artifacts from the stent in nuclear spin tomography.
Dependencies are inferred from the claim text.